About Us.
Our mission
Skyline Diagnostics is a leader in the field of molecular diagnostics through developing and commercializing innovative, signature-based diagnostics with a high clinical value that help to provide physicians and patients with the best individual care possible.
-
Introducing Skyline
At Skyline Diagnostics we are pioneers, translating life sciences into the daily practice of clinical diagnostics.
Read more >> -
Vision & History
At Skyline Diagnostics we firmly believe that we can revolutionize the practice of treating cancer, starting with blood cancers.
Read more >> -
Leadership
Kurt Schmidt, CPA, MBA, joined Skyline in September 2012 bringing with him close to 30 years of operational, financial, and entrepreneurial management experience primarily in the high tech and healthcare industries in the U.S. and Europe.
Read more >> -
Careers
Skyline Diagnostics B.V. is a young ambitious biotech company started by the departments Hematology and Bioinformatics of the Erasmus Medical Center in Rotterdam.We develop in vitro diagnostic microarrays for oncology based on the Affymetrix™ Genechip® technology.
Read more >>
-
-
News
-
10/02/2013 - by Skyline Diagnostics | Posted in: Events
Skyline's method for detecting CEBPA dm accepted for publication
Skyline's method for detecting CEBPA double mutations accepted for publication
Read more -
04/01/2013 - by Skyline Diagnostics | Posted in: Events
STW funds ‘Genes in space’ project
Skyline Diagnostics is proud to be a partner in the ‘Genes in space’ project, in which it will collaborate with...
Read more -
04/01/2013 - by Skyline Diagnostics | Posted in: Events
Skyline's method for detecting NPM1 mutations accepted for publication
The AMLprofiler microarray assay employs custom designed probes to detect mutations in NPM1.
Read more
-
Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com
